These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3088176)

  • 21. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
    Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to influenza in ferrets. XII. Immunization of ferrets with TNBP-split influenza virus vaccine.
    McLaren C; Potter CW; Jennings R
    Arch Gesamte Virusforsch; 1974; 45(1-2):99-105. PubMed ID: 4413778
    [No Abstract]   [Full Text] [Related]  

  • 23. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    Petrie JG; Ohmit SE; Truscon R; Johnson E; Braun TM; Levine MZ; Eichelberger MC; Monto AS
    J Infect Dis; 2016 Oct; 214(8):1142-9. PubMed ID: 27095420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccination on renal transplant patients is safe and serologically effective.
    Grekas D; Alivanis P; Kiriazopoulou V; Dioudis C; Sioulis A; Derveniotis V; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):553-6. PubMed ID: 8294168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of vaccine protection from influenza and its complications.
    McCullers JA; Huber VC
    Hum Vaccin Immunother; 2012 Jan; 8(1):34-44. PubMed ID: 22252001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccines purified by zonal ultracentrifugation.
    Filczak K; Semkow R; Wrzos H; Zakrzewski K; Zgorzelska K
    Acta Microbiol Pol A; 1973; 5(3):261-70. PubMed ID: 4769561
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism.
    Winstanley PA; Tjia J; Back DJ; Hobson D; Breckenridge AM
    Br J Clin Pharmacol; 1985 Jul; 20(1):47-53. PubMed ID: 4027135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influenza vaccination. Measurement of antibodies in blood samples before and after vaccination].
    Kolstø AB; Birkeland Flugsrud L; Halvorsrud J
    Tidsskr Nor Laegeforen; 1985 Jun; 105(19-21):1292-4. PubMed ID: 4012738
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune response to influenza vaccination among peritoneal dialysis patients].
    Dogliani M; Fidelio T; Scalzo B; Iacono G; Bagatella M; Piro F
    Minerva Urol Nefrol; 1998 Mar; 50(1):97-100. PubMed ID: 9578667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E; Werner J; Franke G; Paulus W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sero-epidemiological studies on influenza--antibody response of patients receiving hemodialysis to inactivated influenza vaccine].
    Satsuta K; Yoshimoto T; Ishibashi Y; Yasunaga T; Miwa A; Noriki H
    Kansenshogaku Zasshi; 1983 Mar; 57(3):252-9. PubMed ID: 6413604
    [No Abstract]   [Full Text] [Related]  

  • 35. [Correlations between serum and secretory antibodies in persons inoculated with chromatographic influenza vaccine].
    Bichurina MA; Polzik TP; Mikhaĭlova GN; Ishkil'din MI
    Tr Inst Im Pastera; 1979; 52():75-82. PubMed ID: 550549
    [No Abstract]   [Full Text] [Related]  

  • 36. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of influenza by vaccines administered intramuscularly and intradermally].
    Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC
    Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 40. Influenza 1980-1.
    Br Med J; 1980 Aug; 281(6239):527-8. PubMed ID: 7427354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.